Coley Pharmaceutical Group, Inc. COLY
United States C Corporation
 |
No tags have been applied so far. Sign in to add some. |
|
|
Go Pro to view an analysis and graphs of case roles, types and more.
Inside Counsel (0)
Go Pro to view corporate inside counsel.
Outside Counsel (16)
|
|
A. |
Ph.d |
Maria |
Wolf, Greenfield & Sacks, PC |
BOSTON, MA |
|
|
|
C. |
Ph.d |
Helen |
Wolf, Greenfield & Sacks, PC |
Boston, MA |
|
|
|
EL-HAYEK |
ROQUE |
|
|
Boston, MA |
|
|
|
GATES |
EDWARD |
|
Wolf, Greenfield & Sacks, PC |
Boston, MA |
|
|
|
Gates |
Edward |
R. |
|
Boston, MA |
|
|
|
Knott |
Gail |
|
OFFICE OF RESEARCH & DEVELOPMENT |
Baltimore, MD |
|
|
|
Lockhardt |
Helen |
C. |
Wolf, Greenfield & Sacks, PC |
|
|
|
|
Lockhart |
Helen |
|
Wolf, Greenfield & Sacks, PC |
Boston, MA |
|
|
|
Lockhart |
Helen |
C. |
|
BOSTON, MA |
|
|
|
Martin |
Lisa |
|
Direct: 617-646-8265 |
Boston, MA |
|
|
|
Placeholder |
TTAB |
Attorney |
Direct: 617-646-8265 |
Hamilton, Ontario L8p4z5, MA |
|
|
|
Plaza |
Federal |
Reseve |
Wolf, Greenfield & Sacks, PC |
Boston, MA |
|
|
|
R.h. |
Waller |
Patrick |
|
Boston, MA |
|
|
|
Sacks |
Wolf |
Greenfield |
|
Boston, MA |
|
|
|
Smith |
Chalin |
|
|
ALEXANDRIA, VA |
|
|
|
Trevisan |
Maria |
|
Wolf, Greenfield & Sacks, PC |
Boston, MA |
|
|
|
|
2/13/2008 |
|
SC 13G/A |
|
|
|
|
2/13/2008 |
|
SC 13G/A |
|
|
|
|
2/6/2008 |
|
SC 13G/A |
|
|
|
|
1/31/2008 |
Bate Kenneth |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
1/25/2008 |
Krieg, Arthur M. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
1/25/2008 |
Abdalian Charles H Jr |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
1/25/2008 |
Massari Ferdinand E |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
1/25/2008 |
Bratzler, Robert L. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
1/25/2008 |
Hugin, Robert J. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
1/25/2008 |
Langlois, Patrick |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
1/25/2008 |
Karobath Manfred E |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
1/4/2008 |
|
SC 13D |
|
|
|
|
1/4/2008 |
|
8-K |
Current report pursuant to Section 13 or 15(d) |
|
|
|
1/4/2008 |
Pfizer, Inc. |
3 |
Initial statement of beneficial ownership of securities |
|
|
|
1/4/2008 |
|
25-NSE |
|
|
|
|
1/4/2008 |
|
15-12G |
|
|
|
|
1/3/2008 |
|
SC 13D/A |
|
|
|
|
12/31/2007 |
|
SC TO-T/A |
|
|
|
|
12/21/2007 |
|
SC 13D |
|
|
|
|
12/18/2007 |
|
SC TO-T/A |
|
|
|
|
12/14/2007 |
Karobath Manfred E |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
11/30/2007 |
|
SC TO-T |
|
|
|
|
11/30/2007 |
|
SC 14D9 |
|
|
|
|
11/28/2007 |
|
SC14D9C |
|
|
|
|
11/20/2007 |
|
8-K/A |
|
|
|
|
11/19/2007 |
|
SC 13G/A |
|
|
|
|
11/16/2007 |
|
SC14D9C |
|
|
|
|
11/16/2007 |
|
SC14D9C |
|
|
|
|
11/16/2007 |
|
SC TO-C |
|
|
|
|
11/16/2007 |
|
8-K |
Current report pursuant to Section 13 or 15(d) |
|
|
|
11/2/2007 |
|
10-Q |
|
|
|
|
11/1/2007 |
|
8-K |
Current report pursuant to Section 13 or 15(d) |
|
|
|
10/9/2007 |
|
8-K |
Current report pursuant to Section 13 or 15(d) |
|
|
|
10/9/2007 |
|
8-A12B |
|
|
|
|
9/20/2007 |
Abdalian Charles H Jr |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
9/20/2007 |
Bratzler, Robert L. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
9/20/2007 |
Massari Ferdinand E |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
9/20/2007 |
Krieg, Arthur M. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
9/7/2007 |
|
S-8 |
|
|
|
|
8/29/2007 |
Krieg, Arthur M. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
8/8/2007 |
|
10-Q |
|
|
|
|
8/2/2007 |
|
8-K |
Current report pursuant to Section 13 or 15(d) |
|
|
|
7/20/2007 |
|
SC 13G |
|
|
|
|
6/29/2007 |
|
8-K |
Current report pursuant to Section 13 or 15(d) |
|
|
|
6/22/2007 |
|
8-K |
Current report pursuant to Section 13 or 15(d) |
|
|
|
6/15/2007 |
|
8-K |
Current report pursuant to Section 13 or 15(d) |
|
|
|
6/15/2007 |
Bate Kenneth |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
6/15/2007 |
Hugin, Robert J. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
6/15/2007 |
Langlois, Patrick |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
6/15/2007 |
Karobath Manfred E |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
|
6/19/2014 |
Pfizer Animal Health S.a. |
Assignee |
Application Publication |
13699997 20130084306 |
Vaccines Comprising Cholesterol And Cpg As Sole Adjuvant-carrier Molecul... Vaccines Comprising Cholesterol And Cpg As Sole Adjuvant-carrier Molecul... |
|
|
|
6/19/2014 |
Pfizer Animal Health S.a. |
Assignee |
Application Publication Patent |
13699997 20130084306 10456463 |
Vaccines Comprising Cholesterol And Cpg As Sole Adjuvant-carrier Molecul... Vaccines Comprising Cholesterol And Cpg As Sole Adjuvant-carrier Molecul... Vaccines Comprising Cholesterol And Cpg As Sole Adjuvant-carrier Molecul... |
|
|
|
3/20/2014 |
Krieg, Arthur M. |
Assignor |
Application Publication |
12946379 20110244025 |
Modified Oligoribonucleotide Analogs With Enhanced Immunostimulatory Act... Modified Oligoribonucleotide Analogs With Enhanced Immunostimulatory Act... |
|
|
|
3/20/2014 |
Lipford, Grayson B. |
Assignor |
Application Publication |
12946379 20110244025 |
Modified Oligoribonucleotide Analogs With Enhanced Immunostimulatory Act... Modified Oligoribonucleotide Analogs With Enhanced Immunostimulatory Act... |
|
|
|
5/29/2013 |
Pfizer Animal Health S.a. |
Assignee |
Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Publication Patent Patent Patent Patent Patent Patent Patent |
12670697 13360894 10407952 11603978 13046871 13494216 11368333 12946379 20070142315 20110206719 20120258140 20060172966 20110244025 20100272785 20120121648 20030232074 8466124 8658607 8128944 8227447 8153141 7662949 8354522 |
Immunostimulatory G, U-containing oligoribonucleotides Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Modified Oligoribonucleotide Analogs With Enhanced Immunostimulatory Act... Immunostimulatory Oligoribonucleotides Immunostimulatory G, U-containing oligoribonucleotides Immunostimulatory Oligoribonucleotides Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Immunostimulatory G, U-containing Oligoribonucleotides Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Modified Oligoribonucleotide Analogs With Enhanced Immunostimulatory Act... Immunostimulatory G, U-containing oligoribonucleotides Immunostimulatory Oligoribonucleotides Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Immunostimulatory Oligoribonucleotides Immunostimulatory G, U-containing oligoribonucleotides Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Immunostimulatory G, U-containing Oligoribonucleotides Immunostimulatory Oligoribonucleotides Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Immunostimulatory Oligoribonucleotides |
|
|
|
3/20/2013 |
Uhlmann, Eugen |
Assignor |
Application Publication Patent |
13690791 20130164333 9156875 |
Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... |
|
|
|
3/20/2013 |
Debelak, Harald |
Assignor |
Application Publication Patent |
13690791 20130164333 9156875 |
Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... |
|
|
|
3/20/2013 |
Uhlmann, Eugen |
Assignee |
Application Publication Patent |
13609791 20140069094 9121304 |
Outer Race Locating Washer Outer Race Locating Washer Outer Race Locating Washer |
|
|
|
3/20/2013 |
Uhlmann, Eugen |
Assignee |
Application Publication Patent |
13690791 20130164333 9156875 |
Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... |
|
|
|
11/30/2012 |
Debelak, Harald |
Assignor |
Application Publication Patent |
13690791 20130164333 9156875 |
Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... |
|
|
|
11/30/2012 |
Ullman, Eugen |
Assignor |
Application Publication Patent |
13690791 20130164333 9156875 |
Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... |
|
|
|
11/30/2012 |
Ullman, Eugen |
Assignee |
Application Publication Patent |
13690791 20130164333 9156875 |
Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... |
|
|
|
9/7/2011 |
Uhlmann, Eugen |
Assignee |
Application Publication |
11706561 20080045473 |
Compositions and methods for oligonucleotide formulations Compositions and methods for oligonucleotide formulations |
|
|
|
9/7/2011 |
Vollmer, Jorg |
Assignee |
Application Publication |
11706561 20080045473 |
Compositions and methods for oligonucleotide formulations Compositions and methods for oligonucleotide formulations |
|
|
|
8/11/2011 |
3m Innovative Properties Company |
Assignee |
Application Application Application Application Application Application Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Publication Publication Publication Publication Patent Patent ...and 14 more |
10456308 10165229 10670957 10916125 10933658 11459489 11275553 10595058 10165453 10165002 10013060 10011921 10013202 10012599 20060111387 20080114019 20030158192 20030065005 20030212091 20020193396 20040010007 20040132766 20050032830 20050054640 20060252792 6545017 6525064 ...and 14 more |
Sulfonamido Ether Substituted Imidazoquinolines Ether Substituted Imidazopyridines Aryl Ether Substituted Imidazoquinolines 1-amino 1h-imidazoquinolines Heterocyclic Ether Substituted Imidazoquinolines Ether Substituted Imidazopyridines Urea Substituted Imidazoquinoline Ethers 1h-imidazo Dimers Hydroxylamine Substituted Imidazoquinolines Amide Substituted Imidazopyridines Ether Substituted Imidazopyridines Aryl Substituted Imidazoquinolines Sulfonamido Substituted Imidazopyridines Sulfonamido Ether Substituted Imidazoquinolines Ether Substituted Imidazopyridines Aryl Ether Substituted Imidazoquinolines 1-amino 1h-imidazoquinolines Heterocyclic Ether Substituted Imidazoquinolines Ether Substituted Imidazopyridines Urea Substituted Imidazoquinoline Ethers 1h-imidazo Dimers Urea Substituted Imidazopyridines Ether Substituted Imidazopyridines Hydroxylamine Substituted Imidazoquinolines Sulfonamido Substituted Imidazopyridines Sulfonamido Ether Substituted Imidazoquinolines Aryl Substituted Imidazoquinolines ...and 14 more |
|
|
|
4/25/2011 |
3m Innovative Properties Company |
Assignee |
Application Publication Patent |
10739787 20040147543 7091214 |
Aryl Substituted Imidazoquinolines Aryl Substituted Imidazoquinolines Aryl Substituted Imidazoquinolines |
|
|
|
4/22/2011 |
3m Innovative Properties Company |
Assignee |
Application Application Publication Publication Patent Patent |
10696477 11132537 20040097736 20050209267 6949649 7288550 |
Thioether Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines |
|
|
|
4/22/2011 |
3m Innovative Properties Company |
Assignee |
Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication ...and 32 more |
10166321 10734306 09820420 10696684 10011670 10669051 10013059 10826836 10165449 11068207 11101369 10165222 09589216 11133425 10425054 10848893 11097715 09589580 10027218 10027272 20020173655 20040204438 20050143413 20030187016 20050197358 20030100764 20050209268 ...and 32 more |
Sulfonamide And Sulfamide Substituted Imidazoquinolines Sulfonamide And Sulfamide Substituted Imidazoquinolines Amide Substituted Imidazoquinolines Amido Ether Substituted Imidazoquinolines Amide Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Amide Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Method For The Treatment Of Dermal Lesions Caused By Envenomation Sulfonamide And Sulfamide Substituted Imidazoquinolines Amido Ether Substituted Imidazoquinolines Sulfonamide And Sulfamide Substituted Imidazoquinolines Amido Ether Substituted Imidazoquinolines Sulfonamide And Sulfamide Substituted Imidazoquinolines And Methods For ... Sulfonamide Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Sulfonamide And Sulfamide Substituted Imidazoquinolines Sulfonamide And Sulfamide Substituted Imidazoquinolines Pyrazolopyridines And Analogs Thereof Amido Ether Substituted Imidazoquinolines Amide Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Amide Substituted Imidazoquinolines Amide Substituted Imidazoquinolines Sulfonamide And Sulfamide Substituted Imidazoquinolines Method For The Treatment Of Dermal Lesions Caused By Envenomation ...and 32 more |
|
|
|
3/28/2011 |
Bratzler, Robert L. |
Assignor |
Application Publication |
12835000 20110033421 |
Methods Related To Immunostimulatory Nucleic Acid-induced Interferon Methods Related To Immunostimulatory Nucleic Acid-induced Interferon |
|
|
|
3/22/2011 |
3m Innovative Properties Company |
Assignee |
Application Application Publication Publication Patent |
11884060 12165014 20100240693 20090023722 8378102 |
Amide Substituted Imidazoquinolines Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Amide Substituted Imidazoquinolines Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... |
|
|
|
2/22/2011 |
3m Innovative Properties Company |
Assignee |
Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Publication Publication Publication ...and 43 more |
10596890 11813052 10596897 11883665 10599159 11884052 11570611 11570704 11887524 11570709 11991686 11884186 11884191 10595065 11884982 11722585 10595230 10595790 11885005 10595895 11885006 10595959 11887496 10596117 20070259907 20090176821 20090005371 ...and 43 more |
Pyrazolopyridine-1,4-diamines And Analogs Thereof Sulfone Substituted Imidazo Ring Ethers Aryloxy And Arylalkyleneoxy Substituted Thiazoloquinolines And Thiazolon... Substituted Fused [1,2]imidazo[4,5-c] Ring Compounds And Methods Pyrazolopyridines and Analogs Thereof Substituted imidazo ring systems and methods Nitrogen-containing Heterocyclyl Substituted Imidazoquinolines And Imida... Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines Hydroxyalkyl Substituted Imidazoquinoline Compounds And Methods Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines,... Amide Substituted Imidazopyridines, Imidazoquinolines, And Imidazonaphth... Aqueous Gel Formulations Containing Immune Response Modifiers Hydroxyalkyl Substituted Imidazoquinolines Hydroxylamine Substituted Imidazoquinolines Imidazoquinolinyl Sulfonamides Substituted Chiral Fused [1,2]imidazo[4,5-c] Ring Compounds Amide And Carbamate Derivatives Of Alkyl Substituted N-[4-(4-amino-1h-im... Alkoxy substituted imidazoquinolines Arylalkenyl And Arylalkynyl Substituted Imidazoquinolines Multi-Route Administration Of Immune Response Modifier Compounds Method of Preferentially Inducing the Biosynthesis of Interferon Pyrazolopyridine-1,4-diamines And Analogs Thereof Oxime substituted imidazo-containing Compounds Sulfone Substituted Imidazo Ring Ethers Aryloxy And Arylalkyleneoxy Substituted Thiazoloquinolines And Thiazolon... Substituted Imidazoquinolines and Imidazonaphthyridines Pyrazolopyridines and Analogs Thereof ...and 43 more |
|
|
|
1/12/2011 |
3m Company |
Assignor |
Application Patent |
08092014 5352784 |
Fused Cycloalkylimidazopyridines Fused Cycloalkylimidazopyridines |
|
|
|
12/9/2010 |
3m Innovative Properties Company |
Assignee |
Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Publication Patent Patent Patent Patent Patent |
11827648 11887525 11991663 10595049 11570567 11570716 12894032 11722288 20070292456 20080015184 20070287725 20110021554 20080207674 20080070907 20110269965 20100317684 7915281 7906506 8168802 8476292 8221771 |
Amide and Carbamate Derivatives of N-{2-[4-Amino-2- (Ethoxymethyl)-1H-Im... Ring Closing And Related Methods And Intermediates Substituted Chiral Fused [1,2] Imidazo [4,5-c] Ring Compounds And Method... Immune Response Modifier Formulations And Methods Immune Response Modifier Formulations And Methods Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Com... Formulations Containing An Immune Response Modifier Amide And Carbamate Derivatives Of N-{2-[4-amino-2- (ethoxymethyl)-1h-im... Ring Closing And Related Methods And Intermediates Substituted Chiral Fused [1,2] Imidazo [4,5-c] Ring Compounds And Method... Immune Response Modifier Formulations And Methods Immune Response Modifier Formulations And Methods Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Com... Urea Substituted Imidazopyridines, Imidazoquinolines, and Imidazonaphthy... Formulations Containing An Immune Response Modifier Amide and Carbamate Derivatives of N-{2-[4-Amino-2- (Ethoxymethyl)-1H-Im... Ring Closing And Related Methods And Intermediates Substituted Chiral Fused [1,2] Imidazo [4,5-c] Ring Compounds And Method... Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Com... Urea Substituted Imidazopyridines, Imidazoquinolines, and Imidazonaphthy... Formulations Containing An Immune Response Modifier |
|
|
|
11/17/2010 |
Coley Pharmaceutical Group, Ltd. |
Assignor |
Application Publication |
12946806 20110135605 |
Methods And Products Related To Treatment And Prevention Of Hepatitis C ... Methods And Products Related To Treatment And Prevention Of Hepatitis C ... |
|
|
|
11/3/2010 |
3m Innovative Properties Company |
Assignee |
Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Patent Patent Patent Patent Patent Patent Patent |
10595103 10595792 10596895 11570703 11813039 12480471 12173719 20090018122 20090042925 20070167476 20070219228 20080269192 20090318435 20090017076 7897767 7888349 7897609 7943609 7879849 7923429 7897597 |
Aryloxy And Arylalkyleneoxy Substituted Imidazoquinolines Treatment For Cd5+ B Cell Lymphoma Pyrazolopyridines And Analogs Thereof Chiral Fused [1,2]imidazo[4,5-c] Ring Compounds Aryl Substituted Imidazonaphthyridines Piperazine, [1,4]diazepane, [1,4]diazocane, And [1,5]diazocane Fused Imi... Oxime Substituted Imidazoquinolines Treatment For Cd5+ B Cell Lymphoma Aryloxy And Arylalkyleneoxy Substituted Imidazoquinolines Pyrazolopyridines And Analogs Thereof Chiral Fused [1,2]imidazo[4,5-c] Ring Compounds Aryl Substituted Imidazonaphthyridines Piperazine, [1,4]diazepane, [1,4]diazocane, And [1,5]diazocane Fused Imi... Oxime Substituted Imidazoquinolines Treatment For Cd5+ B Cell Lymphoma Aryloxy And Arylalkyleneoxy Substituted Imidazoquinolines Pyrazolopyridines And Analogs Thereof Chiral Fused [1,2]imidazo[4,5-c] Ring Compounds Aryl Substituted Imidazonaphthyridines Piperazine, [1,4]diazepane, [1,4]diazocane, And [1,5]diazocane Fused Imi... Oxime Substituted Imidazoquinolines |
|
|
|
10/5/2010 |
3m Innovative Properties Company |
Assignor |
Application Publication Patent |
12480471 20090318435 7879849 |
Pyrazolopyridines And Analogs Thereof Pyrazolopyridines And Analogs Thereof Pyrazolopyridines And Analogs Thereof |
|
|
|
9/7/2010 |
Coley Pharmaceutical Group, Ltd. |
Assignor |
Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Publication Patent |
12148275 10532746 11183253 11183187 12443224 10816220 11184065 12196201 20100189772 20040235770 20070129320 20090155307 20090017021 20060246035 20060003962 20060287263 7998492 |
Methods and compositions for inducing antigen-specific immune responses Immunostimulatory Nucleic Acid Oil-in-water Formulations And Related Met... Methods and products related to treatment and prevention of hepatitis C ... Methods And Products Related To Treatment And Prevention Of Hepatitis C ... Methods and compositions for inducing innate immune responses Methods and compositions for inducing innate immune responses Immunostimulatory Nucleic Acid Oil-in-water Formulations And Related Met... Immunostimulatory nucleic acid oil-in-water formulations and related met... Methods And Products Related To Treatment And Prevention Of Hepatitis C ... Compositions of TLR ligands and antivirals Methods and compositions for inducing innate immune responses Methods and compositions for inducing antigen-specific immune responses Immunostimulatory nucleic acid oil-in-water formulations and related met... Methods and products related to treatment and prevention of hepatitis C ... Methods And Products Related To Treatment And Prevention Of Hepatitis C ... Compositions of TLR ligands and antivirals Methods and compositions for inducing innate immune responses |
|
|
|
8/12/2010 |
Bratzler, Robert L. |
Assignor |
Application Publication |
12835000 20110033421 |
Methods Related To Immunostimulatory Nucleic Acid-induced Interferon Methods Related To Immunostimulatory Nucleic Acid-induced Interferon |
|
|
|
6/18/2010 |
Cpg Immunopharmaceuticals, Inc. |
Assignor |
Application Publication Patent |
10956494 20050233999 7879810 |
Immunostimulatory Nucleic Acid Molecules Immunostimulatory Nucleic Acid Molecules Immunostimulatory Nucleic Acid Molecules |
|
|
|
5/19/2010 |
Heppner, Philip D. |
Assignor |
Application Application Publication Publication Patent Patent |
11884060 11884060 20100240693 20100240693 8378102 8378102 |
Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... |
|
|
|
5/19/2010 |
Kshirsagar, Tushar A. |
Assignor |
Application Application Publication Publication Patent Patent |
11884060 11884060 20100240693 20100240693 8378102 8378102 |
Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... |
|
|
|
5/19/2010 |
Lundquist, Gregory D., Jr. |
Assignor |
Application Application Publication Publication Patent Patent |
11884060 11884060 20100240693 20100240693 8378102 8378102 |
Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... |
|
|
|
5/11/2010 |
Krieg, Arthur M. |
Assignor |
Application Publication |
12600364 20100285041 |
Class A Oligonucleotides with Immunostimulatory Potency Class A Oligonucleotides with Immunostimulatory Potency |
|
|
|
4/14/2010 |
Cpg Immunopharmaceuticals, Inc. |
Assignor |
Application Publication |
10435656 20050277604 |
Immunostimulatory nucleic acid molecules Immunostimulatory nucleic acid molecules |
|
|
|
4/12/2010 |
University Of Maryland, Baltimore |
Assignor |
Application Publication |
12083993 20090220522 |
Detoxified Endotoxin Vaccine and Adjuvant and Uses thereof Detoxified Endotoxin Vaccine and Adjuvant and Uses thereof |
|
|
|
4/12/2010 |
Memorial Hospital Of Rhode Island |
Assignor |
Application Publication |
12083993 20090220522 |
Detoxified Endotoxin Vaccine and Adjuvant and Uses thereof Detoxified Endotoxin Vaccine and Adjuvant and Uses thereof |
|
|
|
11/13/2009 |
Cpg Immunopharmaceuticals, Inc. |
Assignor |
Application Publication Patent |
11598207 20080031936 8258106 |
Immunostimulatory Nucleic Acid Molecules Immunostimulatory Nucleic Acid Molecules Immunostimulatory Nucleic Acid Molecules |
|
|
|
7/8/2009 |
Krieg, Arthur M. |
Assignor |
Application Publication Patent |
12472335 20090311277 8114419 |
Nucleic Acid Compositions For Stimulating Immune Responses Nucleic Acid Compositions For Stimulating Immune Responses Nucleic Acid Compositions For Stimulating Immune Responses |
|
|
|
2/20/2009 |
Krieg, Arthur M. |
Assignor |
Application Publication Patent |
11542845 20070224210 8304396 |
Immunostimulatory Nucleic Acids Immunostimulatory Nucleic Acids Immunostimulatory Nucleic Acids |
|
|
|
2/9/2009 |
Krieg, Arthur M. |
Assignor |
Application Publication Patent |
12336986 20090137519 7795235 |
Semi-soft C-class Immunostimulatory Oligonucleotides Semi-soft C-class Immunostimulatory Oligonucleotides Semi-soft C-class Immunostimulatory Oligonucleotides |
|
|
|
1/26/2009 |
3m Innovative Properties Company & 3m Co... |
Assignor |
Application Publication Patent |
11991686 20090176821 8188111 |
Amide And Carbamate Derivatives Of Alkyl Substituted N-[4-(4-amino-1h-im... Amide And Carbamate Derivatives Of Alkyl Substituted N-[4-(4-amino-1h-im... Amide And Carbamate Derivatives Of Alkyl Substituted N-[4-(4-amino-1h-im... |
|
|
|
11/7/2008 |
3m Innovative Properties Company |
Assignor |
Application Publication |
11574464 20090270443 |
1-amino Imidazo-containing Compounds And Methods 1-amino Imidazo-containing Compounds And Methods |
|
|
|
10/6/2008 |
3m Innovative Properties Company & 3m Co... |
Assignor |
Application Publication Patent |
11887525 20110269965 8168802 |
Ring Closing And Related Methods And Intermediates Ring Closing And Related Methods And Intermediates Ring Closing And Related Methods And Intermediates |
|
|
|
9/26/2008 |
3m, Company &. |
Assignor |
Application Publication Patent |
11884153 20100069427 7968563 |
Oxime And Hydroxylamine Substituted Imidazo[4,5-c] Ring Compounds And Me... Oxime And Hydroxylamine Substituted Imidazo[4,5-c] Ring Compounds And Me... Oxime And Hydroxylamine Substituted Imidazo[4,5-c] Ring Compounds And Me... |
|
|
|
9/17/2008 |
3m Innovative Properties Company & 3m Co... |
Assignor |
Application Publication |
11887496 20090075980 |
Pyrazolopyridines and Analogs Thereof Pyrazolopyridines and Analogs Thereof |
|
|
|
9/3/2008 |
3m Innovative Properties Company & 3m Co... |
Assignor |
Application Publication Patent |
11884982 20090030031 8846710 |
Method of Preferentially Inducing the Biosynthesis of Interferon Method of Preferentially Inducing the Biosynthesis of Interferon Method of Preferentially Inducing the Biosynthesis of Interferon |
|
|
|
6/18/2008 |
3m, Company &. |
Assignor |
Application Publication Patent |
11884191 20090099161 8658666 |
Substituted Imidazoquinolines and Imidazonaphthyridines Substituted Imidazoquinolines and Imidazonaphthyridines Substituted Imidazoquinolines and Imidazonaphthyridines |
|
|
|
6/17/2008 |
3m, Company &. |
Assignor |
Application Publication Patent |
11887524 20090124611 7943610 |
Pyrazolopyridine-1,4-diamines And Analogs Thereof Pyrazolopyridine-1,4-diamines And Analogs Thereof Pyrazolopyridine-1,4-diamines And Analogs Thereof |
|
|
|
6/17/2008 |
3m, Company &. |
Assignor |
Application Publication Patent |
11885005 20090029988 8178677 |
Hydroxyalkyl Substituted Imidazoquinolines Hydroxyalkyl Substituted Imidazoquinolines Hydroxyalkyl Substituted Imidazoquinolines |
|
|
|
5/28/2008 |
3m Innovative Properties Company & 3m Co... |
Assignor |
Application Publication Patent |
11885006 20090069314 8158794 |
Hydroxyalkyl Substituted Imidazoquinoline Compounds And Methods Hydroxyalkyl Substituted Imidazoquinoline Compounds And Methods Hydroxyalkyl Substituted Imidazoquinoline Compounds And Methods |
|
|
|
5/23/2008 |
3m, Company &. |
Assignor |
Application Publication Patent |
11883665 20090163532 9248127 |
Aqueous Gel Formulations Containing Immune Response Modifiers Aqueous Gel Formulations Containing Immune Response Modifiers Aqueous Gel Formulations Containing Immune Response Modifiers |
|
|
|
5/12/2008 |
3m, Company &. |
Assignor |
Application Publication |
11884052 20080318998 |
Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines |
|
|
|
5/8/2008 |
3m, Company &. |
Assignor |
Application Publication Patent |
11884186 20090005371 8093390 |
Substituted Fused [1,2]imidazo[4,5-c] Ring Compounds And Methods Substituted Fused [1,2]imidazo[4,5-c] Ring Compounds And Methods Substituted Fused [1,2]imidazo[4,5-c] Ring Compounds And Methods |
|
|
|
4/4/2008 |
Krieg, Arthur M |
Assignor |
Application Publication |
11988396 20090117132 |
Anti-Ctla-4 Antibody and Cpg-Motif-Containing Synthetic Oligodeoxynucleo... Anti-Ctla-4 Antibody and Cpg-Motif-Containing Synthetic Oligodeoxynucleo... |
|
|
|
3/20/2008 |
3m, Company &. |
Assignor |
Application Application Application Publication Publication Publication Patent Patent |
11722585 11570704 11570716 20080119508 20070208052 20070287725 8026366 7915281 |
Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Com... Aryloxy And Arylalkyleneoxy Substituted Thiazoloquinolines And Thiazolon... Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Com... Aryloxy And Arylalkyleneoxy Substituted Thiazoloquinolines And Thiazolon... Multi-Route Administration Of Immune Response Modifier Compounds Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Com... Aryloxy And Arylalkyleneoxy Substituted Thiazoloquinolines And Thiazolon... Multi-Route Administration Of Immune Response Modifier Compounds |
|
|
|
1/9/2008 |
3m Company |
Assignor |
Application Application Publication Publication |
11570709 11570709 20070259907 20070259907 |
Aryl and Arylalkylenyl Substituted Thiazoloquinolines and Thiazolonaphth... Aryl and Arylalkylenyl Substituted Thiazoloquinolines and Thiazolonaphth... Aryl and Arylalkylenyl Substituted Thiazoloquinolines and Thiazolonaphth... Aryl and Arylalkylenyl Substituted Thiazoloquinolines and Thiazolonaphth... |
|
|
|
11/15/2007 |
3m Company, 3m Innovative Properties Com... |
Assignor |
Application Publication Patent |
10436488 20030232852 6743920 |
Process For Imidazo[4,5-c]pyridin-4-amines Process For Imidazo[4,5-c]pyridin-4-amines Process For Imidazo[4,5-c]pyridin-4-amines |
|
|
Incoming Payments
Outgoing Payments
|
|